PAREXEL Launches Perceptive MyTrials Data-Driven Monitoring
PAREXEL announced the launch of its Perceptive MyTrials Data-Driven Monitoring solution.
PAREXEL announced the launch of its Perceptive MyTrials® Data-Driven Monitoring solution. Developed by PAREXEL Informatics, it is a key component of its Perceptive MyTrials eClinical platform, an integrated suite of applications for managing clinical trials.
Perceptive MyTrials Data-Driven Monitoring an centralized monitoring approach that uses clinical data to guide monitoring activities as an alternative to periodically scheduled monitoring visits. This data can drive decision-making in determining when on-site monitoring visits need to occur and what activities should be undertaken during those visits. Monitoring focused on specific risks offers the potential to enhance patient safety, reduce costs and promote regulatory compliance.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research
May 21st 2025In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.
